Top 17 Brillio investors
The most complete profiles first. Showing 17 of 17.
Chris G.Verified
Venture Capital, Private Equity Firm, Investment Partner · United States
SeedHealth CareEnterprise SoftwareTransportationLife SciencePortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Verified email available
Jeff SchererVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareEnterprise SoftwareTransportationAutomotivePortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Verified email available
John KilgallonVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BSeries AHealth CareEnterprise SoftwareTransportationCryptocurrencyPortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Verified email available
Joseph RobbinsVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareEnterprise SoftwareTransportationCryptocurrencyPortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Verified email available
Nigel WalderVerified
Venture Capital, Private Equity Firm, Investment Partner · United Kingdom
Series BSeries AHealth CareEnterprise SoftwareTransportationCryptocurrencyPortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Verified email available
Siefke MichaelVerified
Venture Capital, Private Equity Firm, Investment Partner · Germany
SeedHealth CareEnterprise SoftwareTransportationLife SciencePortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Verified email available
Stephen ThomasVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareAutonomous VehiclesEnterprise SoftwareTransportationPortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Verified email available
Josh BekensteinVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareEnterprise SoftwareTransportationLife SciencePortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Verified email available
Steve BarnesVerified
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareEnterprise SoftwareTransportationLife SciencePortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Verified email available
Blair Hendrix
Venture Capital, Private Equity Firm, Investment Partner · United States
Series BSeries AHealth CareEnterprise SoftwareTransportationCryptocurrencyPortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Contact details available
John Connaughton
Venture Capital, Private Equity Firm, Investment Partner · United States
Series BSeries AHealth CareEnterprise SoftwareTransportationCryptocurrencyPortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Contact details available
Ken Hanau
Venture Capital, Private Equity Firm, Investment Partner · United States
Series BSeries AHealth CareEnterprise SoftwareTransportationCryptocurrencyPortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Contact details available
Luca Bassi
Venture Capital, Private Equity Firm, Investment Partner · United Kingdom
SeedHealth CareEnterprise SoftwareTransportationLife SciencePortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Contact details available
Robert Ehrhart
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareE-commerceEnterprise SoftwareTransportationPortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Contact details available
Cecile Belaman
Venture Capital, Private Equity Firm, Investment Partner · United Kingdom
Health CareEnterprise SoftwareTransportationLife SciencePortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Contact details available
Kimberly McCaslin
Venture Capital, Private Equity Firm, Investment Partner · United States
Health CareEnterprise SoftwareTransportationLife SciencePortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Contact details available
Michel Plantevin
Venture Capital, Private Equity Firm, Investment Partner · United Kingdom
Health CareEnterprise SoftwareTransportationLife SciencePortfolio: Cerevel Therapeutics, QuVa Pharma, Newlinks Technology, Nutanix and 1 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Brillio investors are on Angel Roster?
Angel Roster lists 17 Brillio investors. 9 of them (53%) include a verified email address.
What types of investors are they?
The most common investor types are Private Equity Firms (17), Venture Capital Firms (17) and Investment Partner Investors (12). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Brillio investors invest in?
Among those that list a stage, the most common are Seed (6), Series B (6) and Series A (5).
Where are Brillio investors based?
Most are based in the United States (12), the United Kingdom (4) and Germany (1).
Which companies have Brillio investors backed?
The most-backed portfolio companies among them are Cerevel Therapeutics (17), Nutanix (17), Newlinks Technology (17) and QuVa Pharma (17).
How do I contact Brillio investors?
Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.